PST 2238: A New Antihypertensive Compound that Modulates the Na-K Pump ‘in Vivo’ and ‘in Vitro’

Hypertension Research - Clinical and Experimental

Volumn 23, Issue , 2000, Pages

  Ferrari, Patrizia ^a,b   Ferrandi, Mara ^a,b   Torielli, Lucia ^a,b   Tripodi, Grazia ^a,b   Bianchi, Giuseppe ^a,b  

^a Prassis Sigma Tau Research Institute   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

adducin; hypertension; ouabainlike factor; pharmacogenomic; therapy

Indexed keywords

17BETA (3 FURYL) 5BETA ANDROSTANE 3BETA,14BETA,17ALPHA TRIOL; ADDUCIN; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CYTOSKELETON PROTEIN; DEOXYCORTICOSTERONE ACETATE; DIGITALIS LIKE FACTOR; DIGITOXIGENIN; DNA; GLYCINE DERIVATIVE; OUABAIN; POTASSIUM ION; SODIUM CHLORIDE; SODIUM ION;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; BIOCHEMISTRY; BLOOD PRESSURE REGULATION; CELL CULTURE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EXPOSURE; DRUG SAFETY; ENZYME ACTIVITY; ESSENTIAL HYPERTENSION; GENETIC POLYMORPHISM; GENETIC TRANSFECTION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; KIDNEY CELL; KIDNEY DISEASE; NONHUMAN; PROTEIN EXPRESSION; RAT; RECEPTOR UPREGULATION; REVIEW; SODIUM RETENTION;

ANDROSTANOLS; ANIMAL; ANTIHYPERTENSIVE AGENTS; BIOLOGICAL TRANSPORT; HUMAN; HYPERTENSION; IN VITRO; NA(+)-K(+)-EXCHANGING ATPASE;

EID: 0033799580     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.23.Supplement_S15     Document Type: Article

References (31)

1. Soubrier F, Lathrop GM: The genetic basis of hypertension. Curr Opin Nephrol Hypertens 1995; 4: 177-181.
2. Lifton RP: Molecular genetics of human blood pressure variation. Science 1996; 272: 676-680.
3. Laragh JH, Lamport B, Sealy J, Alderman MH: Diagnosis ex juvantibus: individual response patterns to drugs reveal hypertension mechanism and simplify treatment. Hypertension 1988; 12: 223-226.
4. Marshall A: Getting the right drug into the right patient. Nat Biotechnol 1997; 15: 1249-1252.
5. Housman D, Ledley FD: Why pharmacogenomics? Why now? Nat Biotechnol 1998; 16: 492-493
6. Ferrari P: Pharmacogenomics: a new approach to individual therapy of hypertension? Curr Opin Nephrol Hypertens 1998; 7: 217-222.
7. Ferrari P, Bianchi G: Lessons from experimental genetic hypertension, in Laragh JH, Brenner BM (eds): Hypertension: Pathophysiology. Diagnosis and Management. New York, Raven Press, 1995, pp 1261-1280.
8. Woolfson RG, de Wardener HE: Primary renal abnormalities in hereditary hypertension. Kidney Int 1996; 50: 717-731.
9. Bianchi G, Tripodi G, Casari G, et al: Two point mutations within the adducin genes are involved in blood pressure variation. Proc Natl Acad Sci USA 1994; 91: 3999-4003.
10. Casari G, Barlassina C, Cusi D, et al: Association of the alpha-adducin locus with essential hypertension. Hypertension 1995; 25: 320-326.
11. Cusi D, Barlassina C, Azzani T, et al: Polymorphism of α-adducin and salt-sensitivity in patients with essential hypertension. Lancet 1997; 349: 1353-1357.
12. Ferrandi M, Tripodi G, Salardi S, et al: Renal Na-K ATPase in genetic hypertension. Hypertension 1996; 28: 1018-1025.
13. Tripodi G, Valtorta F, Torielli L, et al: Hypertension-associated point mutations in the adducin alpha and beta subunits affect actin cytoskeleton and ion transport. J Clin Invest 1996; 97: 2815-2822.
14. Ferrandi M, Salardi S, Tripodi G, et al: Interaction between adducin and Na-K ATPase. Differential effect of hypertension-related human and rat adducin polymorphism. Am J Physiol 1999; 277: H1338-H1349.
15. Ferrandi M, Manunta P, Balzan S, Hamlyn JM, Bianchi G, Ferrari P: Ouabain-like factor quantification in mammalian tissues and plasma: comparison of two independent assays. Hypertension 1997; 30: 886-896.
16. Ferrandi M, Minotti E, Salardi S, Florio M, Bianchi G, Ferrari P: Ouabain-like factor in Milan hypertensive rats. Am J Physiol 1992; 263: F739-F748.
17. Manunta P, Cusi D, Barlassina C, et al: α-Adducin polymorphism and renal sodium handling in essential hypertensive patients. Kidney Int 1998; 53: 1471-1478.
18. Castellano M, Barlassina C, Muiesan ML, et al: Alpha-adducin gene polymorphism and cardiovascular pheno-types in a general population. J Hypertens 1991; 15: 1707-1710.
19. Iwai N, Tamaki S, Nakamura Y, Kinoshita M: Polymorphism of α-adducin and hypertension. Lancet 1997; 350: 369.
20. Ishikawa K, Katsuya T, Sato N, et al: No association between α-adducin 460 polymorphism and essential hypertension in a Japanese population. Am J Hypertens 1998; 11: 502-506.
21. Kato N, Sugiyama T, Nabika T, et al: Lack of association between the alpha-adducin locus and essential hypertension in the Japanese population. Hypertension 1998; 31: 730-733.
22. Glorioso N, Manunta P, Filigheddu F, et al: The role of α-adducin polymorphism in blood pressure and sodium handling regulation may not be excluded by a negative association study. Hypertension 1999, 34: 649-654.
23. Manunta P, Stella P, Rivera R, et al: Left ventricular mass, stroke volume and ouabain-like factor in essential hypertension. Hypertension 1999; 34: 450-456.
24. Ferrandi M, Minotti E, Florio M, Bianchi G, Ferrari P: Age-dependency and dietary influence on the hypothalamic ouabain-like factor in Milan hypertensive rats. J Hypertens 1995; 13: 1571-1574.
25. Manunta P, Rogowski AC, Hamilton BP, Hamlyn JM: Ouabain-induced hypertension in the rat: relationships among plasma and tissue ouabain and blood pressure. J Hypertens 1994; 12: 549-560.
26. Ferrari P, Torielli L, Ferrandi M, et al: PST 2238: a new antihypertensive compound that modulates Na-K ATPase in genetic hypertension. J Pharmacol Exp Ther 1999; 288: 1074-1083.
27. Ferrari P, Ferrandi M, Torielli L, Tripodi G, Melloni P, Bianchi G: PST 2238: a new antihypertensive compound that modulates Na-K ATPase and antagonizes the pressor effect of OLF. Cardiovasc Drug Rev 1999; 17: 39-57.
28. Quadri L, Bianchi G, Cerri A, et al: 17β- (3-Furyl) -5β-androstan-3β, 140, 17α-triol (PST 2238): a very potent antihypertensive agent with a novel mechanism of action. J Med Chem 1997; 40: 1561-1564.
29. Hayward AL, Hinojos CA, Nurowska B, et al: Altered sodium pump alpha and gamma subunit gene expression in nephron segments from hypertensive rats. J Hypertens 1999; 17: 1081-1087.
30. Doris PA: Ouabain in plasma from spontaneously hypertensive rats. Am J Physiol 1994; 266: H360-H364.
31. Tripodi G, Szpirer C, Reina C, Szpirer J, Bianchi G: Polymorphism of y adducin gene in genetic hypertension and mapping of the gene to rat chromosome lq55. Biochem Biophys Res Commun 1997; 237: 685-689.